chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Presented to ER on 12/19/21 with complaints of progressively worsening sob.  She began having cold-like symptoms approximately 9 days ago.  She got tested for COVID on December 14th which came back positive.  She had been doing relatively well until earlier today.  She came back to the ER today to possibly received monoclonal antibody infusion.  Unfortunately she was found to be hypoxic and requiring 4 L of oxygen to maintain her saturations.  She had a full workup performed here including CT angiogram chest which ruled out a PE. Procal and wbc elevated. She feels somewhat better now. Other labwork is unremarkable. Placed on dexamethasone, ceftriaxone, azithromycin, and remdesivir. She improved her oxygenation down to 2 liters. abx for more 3 days. Dexamethasone for 5 days. Vitamin D supp. She will need oxygen 1 liter at rest and 4 liters with activity. Discharged on 12/25/21
This case was reported by a other health professional and described the occurrence of wrong vaccine administered in a 33-month-old female patient who received FLUARIX (batch number 3JE9F, expiry date 30th June 2015. On an unknown date, the patient inadvertently received FLUARIX .5 ml. On an unknown date an unknown time after receiving FLUARIX season, the patient experienced wrong vaccine administered. On an unknown date, the outcome of the wrong vaccine administered was unknown.
Approximately 45 min after receiving Covid vaccine, pt ambulated back to vaccine administration location  and states,  "my throat feels funny".
Second Vaccine Location: Pharmacy. On 6/2/21 (day after 2nd dose) I vomited repeatedly throughout the day, a total of 4 times between 9am and 5pm and was unable to keep any water or Tylenol down at all. I had a strong headache the entire day, which also brought with mental fatigue and overwhelm - I couldn't even manage to watch tv I was so ill, it was hard to concentrate, think or even focus my eyes. Around 5pm, feeling severely dehydrated and realizing the urgent cares would be closing soon I scheduled a telehealth dr. appt. with assistance. (I couldn't sit up or focus long before being overcome with nausea, and it was very hard to think.)The telehealth dr. prescribed me anti nausea medicine - Ondansetron, orally disintegrating tablet, 4mg. Told me to attempt drinking 1tsp water every 10 min. after having the medicine. After taking this medicine and also a dissolving form of tylenol you could put on your tongue, and waiting another hour I was able to begin taking sips of water and sit up. I was able to drink more water over the next few hours and finally some cold plain cereal. I thought I was finally in the clear, however I was surprised that I continued to feel nauseous the next two days and continued to need to take the medicine prescribed (from 6/2 - 6/4). My stomach was so upset from nausea and also I had cramps from beginning my menstrual cycle, but I continued to have stomach aches for the following two days (6/2-6/5). I wondered if it was a side effect from the vaccine or the anti nausea medicine. I also experienced constipation 6/2-6/12, (up to the day of writing this) something I never have an issue with. While I could say it might be related to the medicine, I don't understand why it would continue so long. It has improved somewhat gradually. What was most surprising to me after all of this is I then began to experience having a stutter when speaking, approximately once a day every day since returning to work through June 8th. (6/4 - 6/8). While this might seem minor, I have not ever experienced this in my life, so four times in four days is markedly unusual.
Tetanus injection to left deltoid muscle. 02/10/2005. Some soreness since. Reported redness and swelling 02/15/2005. Seek treatment 02/16/2005 with cold pack topically and motrin 600mg q 6hr. 3 1/2x 3 1/2 inches warm, induration at area with 3x5 inches of erythema distally.
This spontaneous report was received from a nurse refers to a 7 year old patient. No concurrent condition or medical history was reported. On 11-DEC-2008, the patient was vaccinated with ATTENUVAX at 12 months of age. On 05-FEB-2009, the patient was vaccinated with MERUVAX. On 23-OCT-2009, the patient was vaccinated with MMR II, (0.5 ml, subcutaneous). No concomitant therapy was reported. No adverse effects were reported. The outcome of the event was unknown. No product quality issue was involved. Additional information has been requested.
An injection was given on 08/01/00. The patient had symptoms of dizziness which progressed to black outs, fainting, muscle soreness, profuse perspiration, excessive thirst, joint fatigue, shaking, trembling after black outs.
Client was incorrectly administered wrong dose of Pfizer vaccine.  Due to client age 12, she should have received the dose authorized for age 12+, but in error was administered the pediatric Pfizer dose
symptoms day of vaccine: dizziness, lethargy, visual changes ("white flashes"), headache, nightmares  symptoms a problem for about 24 - 36 hours
Patient requested COVID booster of Moderna Bivalent during routine visit. LPN went to medication area and obtained Pfizer vial instead of Moderna (even though they are stored in different refrigerator). Instead of verifying on the vial, she drew up 0.5mL of Pfizer Bivalent and entered the Moderna Bivalent lot number from the daily safety huddle form. Therefore, patient did not receive requested Moderna and received 0.2ml more than suggested Pfizer dose.
Development of huge, hot red welts with smaller red areas surrounding some, but not all, of the welts.  Use of antihistamines and Aveeno.
No events within the first 15 minutes. After 20 minutes, car air conditioner caused a mild tingling on the left corner of my lips. Touching a hand to my left face revealed mild parathesias from my cheekbone to my mandible. No change in motor function, just sensation. Opening my mouth fully highlights the "numb" feeling even at the corner of my mouth. No treatment. Continued monitoring. I  recovered from COVID-19 in late January / early February with no treatment.
Vomiting x 2 days, left neck pain, coughing, runny nose
NONE STATED Follow up 02/14/05: Henoch-Schonlein Following vaccination.
feeling knocked down /sleep in bed/chair; not feel good; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (feeling knocked down /sleep in bed/chair) and MALAISE (not feel good) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 017B21A) for COVID-19 vaccination.     The patient's past medical history included Pacemaker insertion (cardiac) (Patient had a pacemaker in his body at the time of the report.) and Defibrillator/pacemaker insertion (Patient had defibrillator in his body at the time of the report.). Concurrent medical conditions included AFib (Heart function is only 35 percent.). Concomitant products included METOPROLOL, ALLOPURINOL, AMIODARONE HYDROCHLORIDE (AMIODARONE HCL), DIGOXIN, PAROXETINE HYDROCHLORIDE (PAROXETINE HCL), WARFARIN SODIUM and BUMETANIDE for an unknown indication.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (feeling knocked down /sleep in bed/chair) and MALAISE (not feel good). At the time of the report, SOMNOLENCE (feeling knocked down /sleep in bed/chair) and MALAISE (not feel good) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jun-2021, Blood test: normal (normal) Blood work was done from hospital and it was normal..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment of events was reported.
Received Td booster on 10/22-at local senior citizen expo. Report on Sun 10/27 began with pain in Lt shoulder cont thru to Monday. Pt stated burning and itching on injection on Monday pm 10/28/02. Shoulder forearm red and swollen and hot to touch. Went to MD Wed 10/30 for eval was told had allergic reaction to Td treated with Clarinex.
heart palpitations that were on and off for 2 days. Palpitations started approximately 3 days after injection. No prior history of heart palpitations.
Vaccinations given on 9/10/14. Came to clinic on 9/16/14 with blister/rash on cheek and nose and streaking up her face. Temp 100 degrees. Treated with acyclovir.
Varicella vaccine breakthrough. Diagnosed with varicella in our office on 2-20-06. 30 papules and vesicles on torso and extremities. Some crusted. Rash started on 2-17-06. No fever.
Immediate reaction after vaccination. Dizzy, headache, no hearing and disoriented. Treatment: Ammonia and EMT called.
Nausea, headache, emesis approx. (1/2 cup), body and muscle aches.
The pt experienced itchy groin, stomach, legs, progressing to neck and chest. No rash. Treated with calamine lotion and Benadryl provide temporary relief. MD prescribes over the phone hydroxyzine, good relief provided.
no problems @ time of inj;24-48 hrs later pt exp pain in elbow;had trouble gripping & twisting lid off jars;pain went up into shoulder & neck;seeing a RPT for treatments;dx w/tendonitis;denies any pain, numbness, redness or swelling @ inj
This case was reported by a nurse via call center representative and described the occurrence of acute myocarditis in a 8-day-old female patient who received ENGERIX B (batch number 52X7T, expiry date 7th September 2020). In March 2018, the patient received the 1st dose of ENGERIX B. In April 2018, 4 days after receiving ENGERIX B, the patient experienced acute myocarditis (serious criteria hospitalization, GSK medically significant, life threatening and other: as per reporter). The patient was treated with milrinone. On an unknown date, the outcome of the acute myocarditis was recovering/resolving. It was unknown if the reporter considered the acute myocarditis to be related to ENGERIX B. Additional details were provided as follows: The patient received ENGERIX-B on her 4th day of life (March 2018). On 8th day of life (April 2018), the patient was admitted into the hospital for acute myocarditis. The patient required treatment with Milrinone and was admitted into the intensive care unit for 4 days before being discharged. The patient had since recovered and was almost back to 100 percent normal, per the physician. All lab reports, cultures, and testing came back normal, so there was no obvious cause. The reporter was unsure if this was related to the vaccine.
This spontaneous report was received from a medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, drug reactions, allergies and concomitant medications were not reported. On 18-OCT-2018, the patient inadvertently received an expired dose of PNEUMOVAX 23 (strength, dose and route of administration were not provided) (lot # M039060 and expiration date: 22-MAY-2018) for prophylaxis (expired product administered). No adverse effects were reported. The medical assistant enquired when the patient could be revaccinated. There was no product quality complaint (PQC) reported.
Patient received additional dose of flu vaccine. Patient was unaware of previous vaccination.  No adverse effects were noted, patient talking and alert when left the clinic.
This spontaneous report was received 08-MAY-2017 from a licensed practical nurse and refers to a 9 week old infant, unknown gender. There was no information provided about the patient's concurrent condition, concomitant therapy or medical history. On 13-SEP-2016 the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # L046319, expiration date: 28-SEP-2017, dose was not reported), orally. No symptoms were reported. The administered dose of ROTATEQ experienced a temperature excursion of 32 degrees Fahrenheit for 15 minutes and 31 degrees Fahrenheit for 15 minutes. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1608USA012908: US-009507513-1608USA012916: US-009507513-1705USA004981: Original Case: 1608USA012794 ROTATEQ; US-009507513-1705USA004982: US-009507513-1705USA004983: US-009507513-1705USA004984: US-009507513-1705USA004985: US-009507513-1705USA004944: US-009507513-1705USA004952: US-009507513-1705USA004953: US-009507513-1608USA012794: Original Case; US-009507513-1705USA004955: US-009507513-1705USA004956: US-009507513-1705USA004957: US-009507513-1705USA004958: US-009507513-1705USA004959: US-009507513-1705USA004960: US-009507513-1705USA004961: US-009507513-1705USA004962: US-009507513-1705USA004963: US-009507513-1705USA004964: US-009507513-1705USA004966: US-009507513-1705USA004967: US-009507513-1705USA004968: US-009507513-1705USA004973: US-009507513-1705USA004972: US-009507513-1705USA004969: US-009507513-1705USA004970: US-009507513-1705USA004971: US-009507513-1705USA004965: US-009507513-1705USA004942: US-009507513-1705USA004945: US-009507513-1705USA004946: US-009507513-1705USA004947: US-009507513-1705USA004948: US-009507513-1705USA004949: US-009507513-1705USA004950: US-009507513-1705USA004951: US-009507513-1705USA004974: US-009507513-1705USA004975: US-009507513-1705USA004976: US-009507513-1705USA004977: US-009507513-1705USA004978: US-009507513-1705USA004979: US-009507513-1705USA004980: US-009507513-1705USA005004: Original Case: 1608USA012908 VAQTA; US-009507513-1705USA005005: US-009507513-1705USA005006: US-009507513-1705USA005007: US-009507513-1705USA004887: Original Case: 1608USA012916 RECOMBIVAX HB; US-009507513-1705USA004888: US-009507513-1705USA004889: US-009507513-1705USA004890: US-009507513-1705USA004891: US-009507513-1705USA004892: US-009507513-1705USA004893: US-009507513-1705USA004894: US-009507513-1705USA004895: US-009507513-1705USA004896: US-009507513-1705USA004897: US-009507513-1705USA004898: US-009507513-1705USA004899.
Headache, Myalgia, Arthralgia, Angina, Fatigue
3-4 hours after vaccines administered, grandmother noted swelling of left upper arm, redness and warm to the touch. Symptoms persist x 2 days.
wanted to do sleep/sleep all the time; could barely lift her arms; Eyes swelled shut; This is a spontaneous report from a contactable consumer (patient).   A 58-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection, Lot number: not reported) via an unspecified route of administration on an unspecified date in Apr2021 as dose 1, single for covid-19 immunisation. Medical history included cholecystectomy and liver operation where the patient described as they took out her gallbladder and seared her liver from her diaphragm. The patient was in the hospital last year for 9 days The patient concomitant medications were not reported. On an unspecified date in 2021, the patient experienced wanted to do sleep/sleep all the time, could barely lift her arms, eyes swelled shut. The patient could not sleep anymore, her eyes were even swelled shut. All she did sleep all the time, she slept so much her eyes swelled It was reported that she was a real high energy person. Outcome of all the events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained .
pt got shot in left arm on 9/16/20 and on 9/19/20 she noticed a warm red circle area about 3 inches in diameter. the outer edge was located about 2-3 inches away from the original vaccine site.
Sudden and unexplainable brain swelling. 5 brain surgeries and 2 months in hospital care.  Collapse with pain in head and neck. Had to be transported to hospital in ambulance. Taken to emergency surgery. Brain several days later started to swell again and a tube was put in from the brain to the stomach. There was no natural cause that could be found. A Shunt was installed draining CSF and blood from brain to stomach. Short term memory loss is currently present. Patient to this point has miraculously survived but not fully recovered.
Patient was given Moderna shot on 09/27/21, and referred to a Hematologist / Oncologist on 09/30/21 for signs / symptoms of possible hemolytic anemia.  He was ultimately diagnosed with Evans Syndrome by Dr. at hospital.    He was then hospitalized at on 10/30/21 with a severe UGIB and hemorrhagic shock, requiring 55u of PRBC transfusions.  55 units.
Rash on leg; This is a spontaneous report from a contactable consumer (patient's relative). An 83-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection), via an unspecified route of administration on an unspecified date (lot number was not reported) as dose 1, single for COVID-19 immunization. Medical history included urinary tract infection. Concomitant medication included unspecified antibiotic taken for urinary tract infection. On an unspecified date, after the vaccination, the experienced rash on leg. The reporter wanted to know are rashes reported or a potential risk of the vaccine. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Approximately 6 hours after receiving PREVNAR 13, broke out with hives all over body. No other exposures reported. Treated w/OTC BENADRYL & ORAPRED.
About 5-10 minutes post vaccination, experienced severe dizziness, impaired vision, and shortness of breath. Experienced sore throat and nausea about 20-30 minutes post vaccination. All of these side effects lasted under 40 minutes. Shortness of breath and dizziness is still prevalent hours post vaccine, but is mild.
On 8/1/02, MD's office called and said pt seen by MD on 7/30/02 with whelp-like rash on face, arms and legs that occurred after shots were given on 7/15/02. Phone call to mom revealed rash started a week after the shots were received and now is doing fine. A follow up report received 8/27/2002 states: No site reaction.
Dizziness, Headache, Tachypnea, soreness in arm, runny nose, severe fatigue Narrative:
Dizzy, decreased vision, BP 85/42 (pulse 94). Given crackers and water. F/u BP 102/62 (pulse 97). Blood glucose 110.
Withing 5 hours of receiving vaccine developed chills, rigors, followed by oral temperature of 102.1 lasting through next morning (10:45 AM).  Temperature decreased with acetaminophen administration.
Developed fever of 103F on 1/19/14, fever then subsided and developed rash on 1/23/14, they then saw physician.
fever of 101.5, chills, body aches, severe neck and back pain, local redness
Around the time I was considering sleep (9ish) my skin became hot and the internal chill feeling became cold and hot simultaneously.  Some breathing difficulty but unsure if it is serious or not.  I've never been good at figuring out if I am breathing well enough so the added difficulty is a concern.  Symptoms for at least 12 hours now.
Shinrgix 1st dose on 2021, didn't received 2nd; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 74-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (1st dose received in 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.       Linked case(s) involving the same patient:  US2022116412   Additional Information: GSK receipt date:08-AUG-2022 Reporters comment: The patient received only one dose of shingrix on 2021 and did not received 2nd dose  The reporter given consent to follow-up. Additional Supportive information: Till the time of reporting the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. This case was linked with case US2022116412, reported by same reporter.; Sender's Comments:  US-GSK-US2022116412:Same repoter
pt recv vax; w/in 12 hr, exp fever, vomiting;sx continue;illness found to be unrelated to vax; no further info avail;
face and hands turned red; whites of my eyes were red as well; burning up and hot to the touch; small rash on multiple body locations; lump in the back of my throat; My hands swelled; My body temperature was also at a low grade fever; BP, heart rate, and sugar levels were abnormally high; BP, heart rate, and sugar levels were abnormally high; BP, heart rate, and sugar levels were abnormally high; This is a spontaneous report from a contactable consumer (patient). A 37-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for Injection Lot Number: EL9265) via an unspecified route of administration in right arm on 11Feb2021 at 15:30 as dose 2, single (at the age of 37-years-old); and previously received first dose of BNT162B2 (Lot Number:EL8982) via an unspecified route of administration in left arm on 15Jan2021 at 10:30 as dose 1, single (at the age of 37-years-old); both for COVID-19 immunization at hospital. Medical history included Crohn's, Ulcerative Colitis, Premature Menopause; all from an unknown date and unknown if ongoing. Patient had known allergy to sulfa. Concomitant medications within 2 weeks of vaccination included BUPROPION, DHEA, BUSPIRONE, ESTRADIOL; all taken for an unspecified indication, start and stop date were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19 and did not receive any other vaccines within 4 weeks. On 13Feb2021, 2 days after the second vaccination, the patient experienced a small rash on multiple body locations. On 14Feb2021, 3 days after the second vaccine, Patient had  face and hands turned red, and it moved inward to cover the top half of body. The whites of her eyes were red as well. Patient was burning up and hot to the touch all over. No hives and no itching. It was reported on an unspecified date in Feb2021, patient also felt like she had a lump in the back of throat, and experienced hands swelled, body temperature was also at a low-grade fever. At the ED, it was noted patient's Blood pressure (BP), heart rate, and sugar levels were abnormally high and had no history of any of those being high. The patient underwent lab tests and procedures in Feb2021, which included blood glucose, blood pressure measurement, heart rate resulted as high on an unspecified date; and body temperature was low-grade fever on an unspecified date. Since the vaccination, the patient has not been tested for COVID-19. Adverse event resulted in emergency room/department or urgent care. Treatment received was steroids, pepcid, Benadryl. The outcome of events was unknown.  Follow-Up (08Jul2021): Follow-up attempts are completed. No further information is expected.
Test positive on 12/16/22. Also noted to have acute hypoxic respiratory failure probably due to CHF per MD note. IV therapy initiated and hospital stay.
The patient received the incorrect vaccine. She recieved 0.2ml of the magenta cap [ndc: 80777-0283-02] instead of 0.25ml of the blue cap [ndc: 80777-0282-05]
This spontaneous report as received from nurse (Health care worker) refers to a female patient of unknown age. The patient's pertinent medical history was unspecified. In April 2013 the patient was vaccinated with ZOSTAVAX for vaccination. Concomitant medications were unspecified. On an unknown date the patient experienced diagnosed with shingles involving one leg. The patient sought medical attention by calling the office of the reporting nurse. The outcome of shingles was unknown. The causality was not reported. Additional information has been requested.
Patient came in for flu shot. About 10 minutes after receiving the vaccine, the patient's mom reported the patient fainted. This lasted for a few seconds. He came back to the pharmacy and reported dizziness and some nausea. His BP was 119/71. He felt better and went home after an hour.